Boehringer Ingelheim rebrands CMO unit; Vetter prepares for increased demand for filling services;

 @NesaNFierce: Not shocked that the Philippines and Indonesia are eyed as emerging leaders in outsourcing. Population means a lot. More | Follow @NesaNFierce

> German pharmaceutical company Boehringer Ingelheim is rebranding its CMO unit as BioXcellence. More

> Roowin, a French CRO, has moved its operations to the French town of Riom. Release

> Pharm-Olam has signed a multiyear, multimillion-dollar contract to use the Datatrak One software solution for supporting Phase I through Phase IV drug and devices studies in multiple languages throughout the world. Release

> With filling services on the rise for CMOs, Vetter has prepared itself for the trend, announcing that it will build a "state-of-the-art, high-performance" filling line for syringes at its Ravensburg Vetter South location in Germany. Release

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.